2010
DOI: 10.1016/j.vaccine.2009.09.071
|View full text |Cite
|
Sign up to set email alerts
|

Immunotherapy with the saponin enriched-Leishmune® vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
50
0
5

Year Published

2010
2010
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(55 citation statements)
references
References 50 publications
0
50
0
5
Order By: Relevance
“…These antigens were used in conjunction with saponin, an adjuvant that has been used in studies involving VL or cutaneous leishmaniasis in mice and dogs (Santos et al 2002, Nico et al 2007, Fernandes et al 2008, Borja-Cabrera et al 2010. We found that both vaccine candidates were able to reduce parasite load in the liver, but that only the L. amazonensis immunogenic extract reduced the parasite load of the spleen.…”
Section: Discussionmentioning
confidence: 69%
“…These antigens were used in conjunction with saponin, an adjuvant that has been used in studies involving VL or cutaneous leishmaniasis in mice and dogs (Santos et al 2002, Nico et al 2007, Fernandes et al 2008, Borja-Cabrera et al 2010. We found that both vaccine candidates were able to reduce parasite load in the liver, but that only the L. amazonensis immunogenic extract reduced the parasite load of the spleen.…”
Section: Discussionmentioning
confidence: 69%
“…From experimental studies, it has been known that these wild animals do not often reveal symptoms and experience frequent re-infections [1,16,17]. Such evidence helps us to assume that all individuals never die of the infection and acquire immunity, and thus, to adopt an susceptible-infectious-susceptible (SIS) model [18][19][20][21][22][23][24].…”
Section: Methodsmentioning
confidence: 99%
“…Οι εμβολιασμένοι σκύλοι γίνονται ορολογικά θετικοί, αλλά μπορούν να διαφοροποιηθούν από τους φυσικά μολυσμένους με την κυτταρομετρία ροής (de Andrade et al 2007). Το εμβόλιο αυτό έχει χρησιμο ποιηθεί και σε ασθενείς σκύλους, σε συνδυασμό με την κλασική αντιλεϊσμανιακή θεραπεία, με ενθαρ ρυντικά αποτελέσματα (Borja-Cabrera et al 2010). Πρόσφατα εγκρίθηκε και ένα άλλο αντιλεϊσμανιακό εμβόλιο (Canileish, Virbac) για ορισμένες χώρες της Ευρωπαϊκής Ένωσης, μεταξύ των οποίων και η Ελλά δα.…”
Section: πόσο χρήσιμος είναι ο εμβολιασμός για τη λεϊσμα-νίωση τον σκunclassified